The adult uterus undergoes repeated cycles of "injury and repair" in response to hormonal signals during the estrous cycle in mice (or the menstrual cycle in primates) numerous times in a normal mammalian reproductive lifespan, as well as during pregnancy when it grows ten-fold to accommodate the fetus. Although this process of remodeling is essential for reproduction, the molecular mechanisms involved are largely unknown, particularly in primates where the top layer of the endometrium is shed and regenerated every month. The principal investigators have shown that conditional deletion of ?-catenin in the Mullerian duct mesenchyme results in a progressive replacement of uterine smooth muscle cells in the myometrium with adipose tissue. They have also shown that the converse experiment with conditional expression of a gain-of-function allele of ?-catenin results in myometrial smooth muscle hyperplasia and development of stromal sarcomas and leiomyoma's (uterine fibroids). Both phenotypes were observed only after mice entered sexual maturity, suggesting that the mechanisms disrupted in these mice are regulated by ovarian steroid hormones. The principal investigators hypothesize that disruption of the nuclear function of ?-catenin, a key determinant of stemness in many stem cell microenvironments, in myometrial stem cells leads to these uterine pathologies. They have identified the regenerative myometrial smooth muscle stem cells in mice and in humans and propose to investigate whether endocrine disruptors (1) impact the differentiation and pluripotency of myometrial stem cells in vitro and in vivo during cycling, pregnancy, and leiomyoma development;(2) dysregulate the molecular mechanisms of Wnt/?-catenin signaling in our gain-of-function and loss-of-function models;and (3) alter the differentiation and pluripotency of myometrial stem cells during the perinatal window of myometrial development. The results of these experiments will help determine whether endocrine disruptors have a significant impact on the differentiation and function of myometrial stem cells. Performing these experiments in unique mouse models of dysregulated Wnt/?-catenin signaling will also help determine which of the molecular mechanisms used by ?-catenin, during normal and conditionally disrupted differentiation and in the adult activities of the myometrial stem cells, are affected. The principal investigator predict that an environmentally relevant level of exposure to endocrine disruptors plays an important role in uterine biology, particularly at the myometrial stem cell level and its contribution to uteine fibroid etiology and pathophysiology.

Public Health Relevance

Uterine fibroids afflict approximately 20% of American women during their reproductive years and are a significant source of pelvic pain, abnormal uterine bleeding, and infertility. Uterine fibroids are also the major reason for hysterectomies in the United States. Despite the major health care burden posed by uterine fibroids, very little is known about their cause or the best treatment strategies. The overall aims of the proposed studies are to understand the effects of environmental exposure to endocrine-disrupting compounds (EDCs) on the stem cells that are responsible for uterine fibroid development and determine whether therapeutic intervention at the stem cell level can lead to better management strategies for this disease.

Agency
National Institute of Health (NIH)
Institute
Office of The Director, National Institutes of Health (OD)
Type
Research Project (R01)
Project #
7R01OD012206-02
Application #
8679137
Study Section
Special Emphasis Panel (ZES1-TN-D (ST))
Program Officer
Mirochnitchenko, Oleg
Project Start
2013-08-01
Project End
2017-07-31
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
2
Fiscal Year
2013
Total Cost
$380,489
Indirect Cost
$126,771
Name
Michigan State University
Department
Obstetrics & Gynecology
Type
Schools of Medicine
DUNS #
193247145
City
East Lansing
State
MI
Country
United States
Zip Code
48824